{"disease":{"id":"gastric-cancer-adenocarcinoma-of-esophagogastric-junction","name":"gastric cancer adenocarcinoma of esophagogastric junction"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06277908","title":"Postoperative Morbidity and Mortality After Gastric Cancer Surgery","phase":"","overall_status":"UNKNOWN","enrollment_count":700,"lead_sponsor_name":"P. Herzen Moscow Oncology Research Institute","has_results":false},{"nct_id":"NCT07441785","title":"Immediate and Functional Results of Different Types of Reconstructions After Proximal Gastrectomy For Gastric and Esophagogastric Junction Cancer","phase":"","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"P. Herzen Moscow Oncology Research Institute","has_results":false},{"nct_id":"NCT03045770","title":"mFOLFOX Versus mFOLFIRI Versus FOLFPTX as First-line Treatment in AGC or EGJA","phase":"NA","overall_status":"UNKNOWN","enrollment_count":150,"lead_sponsor_name":"Fujian Cancer Hospital","has_results":false},{"nct_id":"NCT06222944","title":"Anlotinib, TQB2450 (PD-L1 Inhibitor), and Albumin-bound Paclitaxel Regimens in the Treatment of GC/GEJA","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":90,"lead_sponsor_name":"Peking University","has_results":false},{"nct_id":"NCT03030937","title":"Clinical Trial to Compare Apatinib Plus Irinotecan Versus Single Irinotecan as Second-line Treatment in AGC or EGJA","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":74,"lead_sponsor_name":"Fujian Cancer Hospital","has_results":false},{"nct_id":"NCT06158919","title":"A Study of PD-1 Inhibitors Combined With Fruquintinib and Chemotherapy in First-line Treatment of HER2-negative Advanced G/GEJ Cancer","phase":"NA","overall_status":"RECRUITING","enrollment_count":58,"lead_sponsor_name":"Fudan University","has_results":false},{"nct_id":"NCT06300879","title":"A Prospective Study on Esophagogastrostomy by an Innovative Surgical Technique","phase":"NA","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"Huashan Hospital","has_results":false},{"nct_id":"NCT04891900","title":"TQB2450 Plus Anlotinib Combined With Chemotherapy in the Treatment of Gastric or Gastroesophageal Junction Adenocarcinoma","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":25,"lead_sponsor_name":"Henan Cancer Hospital","has_results":false}],"total":8},"guidelines":[],"source":"Drug Landscape verified database"}